Virtu KCG Holdings’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-8,300
Closed -$638K 3329
2015
Q4
$638K Buy
8,300
+4,500
+118% +$339K 0.01% 1274
2015
Q3
$254K Buy
3,800
+900
+31% +$66.3K ﹤0.01% 2288
2015
Q2
$215K Sell
2,900
-900
-24% -$68.8K ﹤0.01% 2496
2015
Q1
$296K Buy
+3,800
New +$288K 0.01% 1935
2014
Q4
Sell
-25,000
Closed -$1.55M 4036
2014
Q3
$1.55M Sell
25,000
-4,500
-15% -$286K 0.03% 634
2014
Q2
$1.88M Sell
29,500
-31,100
-51% -$1.89M 0.03% 576
2014
Q1
$3.73M Buy
60,600
+7,100
+13% +$414K 0.05% 364
2013
Q4
$3.07M Buy
53,500
+20,800
+64% +$1.18M 0.03% 419
2013
Q3
$1.74M Buy
+32,700
New +$1.76M 0.02% 719

Other funds holding MDT

Virtu KCG Holdings's MDT Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Medtronic (MDT) stake by 66% in Q2 2017, selling an estimated $2.36M and leaving 14,238 shares worth $1.26M. The position accounts for 0.04% of the portfolio, ranked #451.

Virtu KCG Holdings first reported a position in MDT in Q3 2013 and has held it in 16 quarters since. The position peaked at $8.3M in Q4 2016. 1,280 funds tracked by Wall St. Rank hold MDT as of Q2 2017.

  • Virtu KCG Holdings held 14,238 shares of Medtronic worth $1.26M as of Q2 2017.
  • Virtu KCG Holdings sold 28,000 Medtronic shares in Q2 2017, an estimated $2.36M.
  • Medtronic made up 0.04% of Virtu KCG Holdings's portfolio in Q2 2017, its #451 holding.
  • Virtu KCG Holdings first reported a position in Medtronic in Q3 2013 and has held it in 16 quarters since.
  • Virtu KCG Holdings's Medtronic position peaked at $8.3M in Q4 2016.
  • 1,280 funds tracked by Wall St. Rank held Medtronic as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.